Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (32)
Yangchun Hong, Zhen Li, Yixin Su, Hexian Pu & Xiuxiu Zhang. (2024) The ceRNA Mechanism of lncRNA MEG3/miR-21-5p/SPRY2 in Cell Proliferation and Apoptosis in Bladder Cancer. Critical Reviews in Eukaryotic Gene Expression 34:1, pages 55-68.
Crossref
Crossref
Amirreza Mehmandar-Oskuie, Kasra Jahankhani, Arman Rostamlou, Sepideh Arabi, Zahra Sadat Razavi & Amirhossein Mardi. (2023) Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies. Biomedicine & Pharmacotherapy 165, pages 115242.
Crossref
Crossref
Yucheng Meng, Ke Huang, Mingxuan Shi, Yifei Huo, Liang Han, Bin Liu & Yi Li. (2023) Research Advances in the Role of the Tropomyosin Family in Cancer. International Journal of Molecular Sciences 24:17, pages 13295.
Crossref
Crossref
Sulieman Ibraheem Shelash Al-Hawary, Harikumar Pallathadka, Ahmed Hjazi, Ziyadulla Eshmamatovich Zhumanov, Adeeb Abdulally Abdulhussien alazbjee, Shad Imad, Ali Alsalamy, Beneen M. Hussien, Noor Sadiq Jaafer & Reza Mahmoudi. (2023) ETS transcription factor ELK3 in human cancers: An emerging therapeutic target. Pathology - Research and Practice 248, pages 154728.
Crossref
Crossref
Irina Gilyazova, Kadriia Enikeeva, Guzel Rafikova, Evelina Kagirova, Yuliya Sharifyanova, Dilara Asadullina & Valentin Pavlov. (2023) Epigenetic and Immunological Features of Bladder Cancer. International Journal of Molecular Sciences 24:12, pages 9854.
Crossref
Crossref
Yiwen Wu, Zhizhong Xie, Sijun Deng, Yiniu Xia, Xiaoyong Lei & Xiaoyan Yang. (2023) Microrna-96 In Human Cancers. Combinatorial Chemistry & High Throughput Screening 26:7, pages 1285-1297.
Crossref
Crossref
Hao Wang, Yanfei Feng, Xiangyi Zheng & Xin Xu. (2023) The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer. Cancers 15:4, pages 1007.
Crossref
Crossref
Ishaq Tantray, Rani Ojha & Aditya P. Sharma. (2023) Non-coding RNA and autophagy: Finding novel ways to improve the diagnostic management of bladder cancer. Frontiers in Genetics 13.
Crossref
Crossref
Lei Zhang, Fuqiang Zhao, Wenfang Li, Guanbin Song, Vivi Kasim & Shourong Wu. (2022) The Biological Roles and Molecular Mechanisms of Long Non-Coding RNA MEG3 in the Hallmarks of Cancer. Cancers 14:24, pages 6032.
Crossref
Crossref
Jie Xu, Xia Wang, Chunming Zhu & Kefeng Wang. (2022) A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Hong Luan, Ye He, Tuo Zhang, Yanna Su & Liping Zhou. (2022) The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma. BMC Cancer 22:1.
Crossref
Crossref
Chenyao Li, Sen Hong, Han Hu, Tao Liu, Guoqiang Yan & Di Sun. (2022)
MYC-Induced Upregulation of Lncrna
ELFN1-AS1
Contributes to Tumor Growth in Colorectal Cancer via Epigenetically Silencing TPM1
. Molecular Cancer Research 20:11, pages 1697-1708.
Crossref
Crossref
Tao Fan, Liang Xue, Bingzheng Dong, Houguang He, Wenda Zhang, Lin Hao, Weiming Ma, Guanghui Zang, Conghui Han & Yang Dong. (2022) CDH1 overexpression predicts bladder cancer from early stage and inversely correlates with immune infiltration. BMC Urology 22:1.
Crossref
Crossref
Lei Wang, Xudong Liu, Miao Yue, Zhe Liu, Yu Zhang, Ying Ma, Jia Luo, Wuling Li, Jiangshan Bai, Hongmei Yao, Yuxuan Chen, Xiaofeng Li, Dayun Feng & Xinqiang Song. (2021)
Identification of hub genes in bladder cancer based on weighted gene co‐expression network analysis from
TCGA
database
. Cancer Reports 5:9.
Crossref
Crossref
Yunkun Yan, Jianchang Li, Mushi Ye, Zhuo Li & Sining Li. (2022) Tropomyosin Is Potential Markers for the Diagnosis and Prognosis of Bladder Cancer. Disease Markers 2022, pages 1-13.
Crossref
Crossref
Zhihui Tian, Jian Zhao & Yusheng Wang. (2021) The prognostic value of TPM1–4 in hepatocellular carcinoma. Cancer Medicine 11:2, pages 433-446.
Crossref
Crossref
Hui-Jin Li, Xue Gong, Zheng-Kun Li, Wei Qin, Chun-Xia He, Lu Xing, Xin Zhou, Dong Zhao & Hui-Ling Cao. (2021) Role of Long Non-coding RNAs on Bladder Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Shiliang Dong, Minrui Ma, Ming Li, Yuexin Guo, Xiaoxiao Zuo, Xiaobin Gu, Mingzhi Zhang & Yonggang Shi. (2021) LncRNA MEG3 regulates breast cancer proliferation and apoptosis through miR-141-3p/RBMS3 axis. Genomics 113:4, pages 1689-1704.
Crossref
Crossref
Hongjian Wu, Wubing Jiang, Guanghua Ji, Rong Xu, Gaobo Zhou & Hongyuan Yu. (2021) Exploring microRNA target genes and identifying hub genes in bladder cancer based on bioinformatic analysis. BMC Urology 21:1.
Crossref
Crossref
Shun Zhang, Lu Li, Jie Wang, Tingting Zhang, Ting Ye, Shuai Wang, Dongming Xing & Wujun Chen. (2021) Recent advances in the regulation of ABCA1 and ABCG1 by lncRNAs. Clinica Chimica Acta 516, pages 100-110.
Crossref
Crossref
Przemysław A. Stempor, Dror Avni, Raya Leibowitz, Yechezkel Sidi, Maria Stępień, Tomasz Dzieciątkowski & Paula Dobosz. (2021) Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells. International Journal of Molecular Sciences 22:5, pages 2553.
Crossref
Crossref
Bixuan Wang. Aberrant expression of long noncoding RNAs in bladder cancer. Aberrant expression of long noncoding RNAs in bladder cancer.
Liwei Meng, Zhaoquan Xing, Zhaoxin Guo & Zhaoxu Liu. (2020) LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression. Cell Death & Disease 11:12.
Crossref
Crossref
Hailing Tang, Qianfa Long, Kun Zhuang, Yuan Yan, Kun Han, Hanqing Guo & Xiaolan Lu. (2019) miR‐665 promotes the progression of gastric adenocarcinoma via elevating FAK activation through targeting SOCS3 and is negatively regulated by lncRNA MEG3. Journal of Cellular Physiology 235:5, pages 4709-4719.
Crossref
Crossref
Wei Xiang, Lintao Han, Guoyan Mo, Li Lin, Xiaoming Yu, Shaowen Chen, Tiexiang Gao & Chunhua Huang. (2019) MicroRNA‐96 is a potential tumor repressor by inhibiting NPTX2 in renal cell carcinoma. Journal of Cellular Biochemistry 121:2, pages 1504-1513.
Crossref
Crossref
Chuan Zhang, Mandy Berndt-Paetz & Jochen Neuhaus. (2020) Identification of Key Biomarkers in Bladder Cancer: Evidence from a Bioinformatics Analysis. Diagnostics 10:2, pages 66.
Crossref
Crossref
Victor G. Martinez, Ester Munera-Maravilla, Alejandra Bernardini, Carolina Rubio, Cristian Suarez-Cabrera, Cristina Segovia, Iris Lodewijk, Marta Dueñas, Mónica Martínez-Fernández & Jesus Maria Paramio. (2019) Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet. Frontiers in Genetics 10.
Crossref
Crossref
Shoudan Zhang & Wenshi Guo. (2019) Long non‑coding RNA MEG3 suppresses the growth of glioma cells by regulating the miR‑96‑5p/MTSS1 signaling pathway. Molecular Medicine Reports.
Crossref
Crossref
Wei Wang, Ying Xie, Fei Chen, Xu Liu, Li-Li Zhong, Hai-Qiang Wang & Qing-Chang Li. (2019) LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer. World Journal of Gastroenterology 25:29, pages 3972-3984.
Crossref
Crossref
Wei Wang, Ying Xie, Fei Chen, Xu Liu, Li-Li Zhong, Hai-Qiang Wang & Qing-Chang Li. (2019) LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer. World Journal of Gastroenterology 25:29, pages 0-0.
Crossref
Crossref
Dan Guo, Yarui Li, Yifei Chen, Dan Zhang, Xin Wang, Guifang Lu, Mudan Ren, Xinlan Lu & Shuixiang He. (2019) DANCR promotes HCC progression and regulates EMT by sponging miR‐27a‐3p via ROCK1/LIMK1/COFILIN1 pathway. Cell Proliferation 52:4.
Crossref
Crossref
Nada Humayun-Zakaria, Roland Arnold, Anshita Goel, Douglas Ward, Stuart Savill & Richard Bryan. (2019) Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer. International Journal of Molecular Sciences 20:5, pages 1102.
Crossref
Crossref